China Bio-protein Drug Industry Market Research Report 2023-2029

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report elaborates on the current development of the Bio-protein Drug industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Amgen Inc

    • Merck

    • Fresenius kabi

    • Dr Reddy’s Laboratories

    • ProBioGen AG

    • Eli Lilly and Company

    • Johnson & Johnson

    • Novartis AG

    • Sanofi

    • GlaxoSmithKline

    • Bayer AG

    • Reliance Life Science Pvt Ltd

    • Biocon Ltd

    By Type:

    • Monoclonal Antibodies

    • Therapeutic Proteins

    • Vaccines

    By Application:

    • Pharma and Biotech Companies

    • CROs

    • Academics

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Bio-protein Drug Market Overview 2018-2029

    • 1.1 China Bio-protein Drug Industry Development Overview

    • 1.2 China Bio-protein Drug Industry Development History

    • 1.3 China Bio-protein Drug Industry Market Size (2018-2029)

    • 1.4 China Bio-protein Drug Market Analysis by Type from Production Side

      • 1.4.1 China Bio-protein Drug Production Volume, Production Value and Growth Rate of Monoclonal Antibodies (2018-2029)

      • 1.4.2 China Bio-protein Drug Production Volume, Production Value and Growth Rate of Therapeutic Proteins (2018-2029)

      • 1.4.3 China Bio-protein Drug Production Volume, Production Value and Growth Rate of Vaccines (2018-2029)

    • 1.5 China Bio-protein Drug Market Analysis by Application from Consumption End

      • 1.5.1 China Bio-protein Drug Sales Volume, Sales Value and Growth Rate of Pharma and Biotech Companies (2018-2029)

      • 1.5.2 China Bio-protein Drug Sales Volume, Sales Value and Growth Rate of CROs (2018-2029)

      • 1.5.3 China Bio-protein Drug Sales Volume, Sales Value and Growth Rate of Academics (2018-2029)

    • 1.6 China Bio-protein Drug Market Analysis by Region

      • 1.6.1 North China Bio-protein Drug Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Bio-protein Drug Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Bio-protein Drug Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Bio-protein Drug Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Bio-protein Drug Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Bio-protein Drug Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Bio-protein Drug Market Size and Growth Rate from 2018-2029

    Chapter 2 China Bio-protein Drug Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Bio-protein Drug Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Bio-protein Drug Market Status and Competition Analysis in 2023

      • 2.2.3 China Bio-protein Drug Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Bio-protein Drug Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Bio-protein Drug Industry Development

    Chapter 3 Bio-protein DrugIndustry Chain Analysis

    • 3.1 Bio-protein Drug Industry Chain

    • 3.2 Bio-protein Drug Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Bio-protein Drug Market

    • 3.3 Bio-protein Drug Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Bio-protein Drug Market

    Chapter 4 China Bio-protein Drug Market, by Type

    • 4.1 China Bio-protein Drug Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Bio-protein Drug Total Production Volume and Growth Rate from Production Side

    • 4.5 China Bio-protein Drug Production Volume and Growth Rate, by Type

      • 4.5.1 China Bio-protein Drug Production Volume and Growth Rate of Monoclonal Antibodies

      • 4.5.2 China Bio-protein Drug Production Volume and Growth Rate of Therapeutic Proteins

      • 4.5.3 China Bio-protein Drug Production Volume and Growth Rate of Vaccines

    Chapter 5 China Bio-protein Drug Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Bio-protein Drug Total Market Size and Growth Rate from Consumption End

    • 5.5 China Bio-protein Drug Market Size and Growth Rate, by Application

      • 5.5.1 China Bio-protein Drug Market Size and Growth Rate of Pharma and Biotech Companies

      • 5.5.2 China Bio-protein Drug Market Size and Growth Rate of CROs

      • 5.5.3 China Bio-protein Drug Market Size and Growth Rate of Academics

    Chapter 6 China Bio-protein Drug Market, by Region

    • 6.1 China Bio-protein Drug Production Volume and Production Value, by Region

    • 6.2 China Bio-protein Drug Sales Volume and Sales Value, by Region

    Chapter 7 North China Bio-protein Drug Market Analysis

    • 7.1 North China Bio-protein Drug Market, by Type

    • 7.2 North China Bio-protein Drug Market, by Application

    Chapter 8 Central China Bio-protein Drug Market Analysis

    • 8.1 Central China Bio-protein Drug Market, by Type

    • 8.2 Central China Bio-protein Drug Market, by Application

    Chapter 9 South China Bio-protein Drug Market Analysis

    • 9.1 South China Bio-protein Drug Market, by Type

    • 9.2 South China Bio-protein Drug Market, by Application

    Chapter 10 East China Bio-protein Drug Market Analysis

    • 10.1 East China Bio-protein Drug Market, by Type

    • 10.2 East China Bio-protein Drug Market, by Application

    Chapter 11 Northeast China Bio-protein Drug Market Analysis

    • 11.1 Northeast China Bio-protein Drug Market, by Type

    • 11.2 Northeast China Bio-protein Drug Market, by Application

    Chapter 12 Southwest China Bio-protein Drug Market Analysis

    • 12.1 Southwest China Bio-protein Drug Market, by Type

    • 12.2 Southwest China Bio-protein Drug Market, by Application

    Chapter 13 Northwest China Bio-protein Drug Market Analysis

    • 13.1 Northwest China Bio-protein Drug Market, by Type

    • 13.2 Northwest China Bio-protein Drug Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Amgen Inc

        • 14.1.1 Amgen Inc Company Profile

        • 14.1.2 Amgen Inc Bio-protein Drug Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Merck

        • 14.2.1 Merck Company Profile

        • 14.2.2 Merck Bio-protein Drug Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Fresenius kabi

        • 14.3.1 Fresenius kabi Company Profile

        • 14.3.2 Fresenius kabi Bio-protein Drug Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Dr Reddy’s Laboratories

        • 14.4.1 Dr Reddy’s Laboratories Company Profile

        • 14.4.2 Dr Reddy’s Laboratories Bio-protein Drug Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 ProBioGen AG

        • 14.5.1 ProBioGen AG Company Profile

        • 14.5.2 ProBioGen AG Bio-protein Drug Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Eli Lilly and Company

        • 14.6.1 Eli Lilly and Company Company Profile

        • 14.6.2 Eli Lilly and Company Bio-protein Drug Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Johnson & Johnson

        • 14.7.1 Johnson & Johnson Company Profile

        • 14.7.2 Johnson & Johnson Bio-protein Drug Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Novartis AG

        • 14.8.1 Novartis AG Company Profile

        • 14.8.2 Novartis AG Bio-protein Drug Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Sanofi

        • 14.9.1 Sanofi Company Profile

        • 14.9.2 Sanofi Bio-protein Drug Market Performance

        • 14.9.3 Product&Service Introduction

      • 14.10 GlaxoSmithKline

        • 14.10.1 GlaxoSmithKline Company Profile

        • 14.10.2 GlaxoSmithKline Bio-protein Drug Market Performance

        • 14.10.3 Product&Service Introduction

      • 14.11 Bayer AG

        • 14.11.1 Bayer AG Company Profile

        • 14.11.2 Bayer AG Bio-protein Drug Market Performance

        • 14.11.3 Product&Service Introduction

      • 14.12 Reliance Life Science Pvt Ltd

        • 14.12.1 Reliance Life Science Pvt Ltd Company Profile

        • 14.12.2 Reliance Life Science Pvt Ltd Bio-protein Drug Market Performance

        • 14.12.3 Product&Service Introduction

      • 14.13 Biocon Ltd

        • 14.13.1 Biocon Ltd Company Profile

        • 14.13.2 Biocon Ltd Bio-protein Drug Market Performance

        • 14.13.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Bio-protein Drug Industry Research Conclusions

    • 15.2 Bio-protein Drug Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Bio-protein Drug Industry Market Size (2018-2029)

    • Figure China Bio-protein Drug Production Volume, Production Value and Growth Rate of Monoclonal Antibodies (2018-2029)

    • Figure China Bio-protein Drug Production Volume, Production Value and Growth Rate of Therapeutic Proteins (2018-2029)

    • Figure China Bio-protein Drug Production Volume, Production Value and Growth Rate of Vaccines (2018-2029)

    • Figure China Bio-protein Drug Sales Volume, Sales Value and Growth Rate of Pharma and Biotech Companies (2018-2029)

    • Figure China Bio-protein Drug Sales Volume, Sales Value and Growth Rate of CROs (2018-2029)

    • Figure China Bio-protein Drug Sales Volume, Sales Value and Growth Rate of Academics (2018-2029)

    • Figure North China Bio-protein Drug Market Size and Growth Rate from 2018-2029

    • Figure Central China Bio-protein Drug Market Size and Growth Rate from 2018-2029

    • Figure South China Bio-protein Drug Market Size and Growth Rate from 2018-2029

    • Figure East China Bio-protein Drug Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Bio-protein Drug Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Bio-protein Drug Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Bio-protein Drug Market Size and Growth Rate from 2018-2029

    • Figure Bio-protein Drug Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Bio-protein Drug Market Share by Type in 2018

    • Figure China Bio-protein Drug Market Share by Type in 2023

    • Figure China Bio-protein Drug Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Bio-protein Drug Production Volume and Growth Rate of Monoclonal Antibodies (2018-2023)

    • Figure China Bio-protein Drug Production Volume and Growth Rate of Therapeutic Proteins (2018-2023)

    • Figure China Bio-protein Drug Production Volume and Growth Rate of Vaccines (2018-2023)

    • Figure China Bio-protein Drug Market Share by Application in 2018

    • Figure China Bio-protein Drug Market Share by Application in 2023

    • Figure China Bio-protein Drug Total Market Size and Growth Rate from Consumption End

    • Figure China Bio-protein Drug Market Size and Growth Rate of Pharma and Biotech Companies (2018-2023)

    • Figure China Bio-protein Drug Market Size and Growth Rate of CROs (2018-2023)

    • Figure China Bio-protein Drug Market Size and Growth Rate of Academics (2018-2023)

    • Table China Bio-protein Drug Production Volume by Region (2018-2023)

    • Table China Bio-protein Drug Production Volume Share by Region (2018-2023)

    • Figure China Bio-protein Drug Production Volume Share by Region (2018-2023)

    • Table China Bio-protein Drug Production Value by Region (2018-2023)

    • Table China Bio-protein Drug Production Value Share by Region (2018-2023)

    • Figure China Bio-protein Drug Production Value Share by Region (2018-2023)

    • Table China Bio-protein Drug Sales Volume by Region (2018-2023)

    • Table China Bio-protein Drug Sales Volume Share by Region (2018-2023)

    • Figure China Bio-protein Drug Sales Volume Share by Region (2018-2023)

    • Table China Bio-protein Drug Sales Value by Region (2018-2023)

    • Table China Bio-protein Drug Sales Value Share by Region (2018-2023)

    • Figure China Bio-protein Drug Sales Value Share by Region (2018-2023)

    • Table North China Bio-protein Drug Production Volume by Type (2018-2023)

    • Table North China Bio-protein Drug Production Volume Share by Type (2018-2023)

    • Figure North China Bio-protein Drug Production Volume Share by Type (2018-2023)

    • Table North China Bio-protein Drug Sales Volume by Application (2018-2023)

    • Table North China Bio-protein Drug Sales Volume Share by Application (2018-2023)

    • Figure North China Bio-protein Drug Sales Volume Share by Application (2018-2023)

    • Table Central China Bio-protein Drug Production Volume by Type (2018-2023)

    • Table Central China Bio-protein Drug Production Volume Share by Type (2018-2023)

    • Figure Central China Bio-protein Drug Production Volume Share by Type (2018-2023)

    • Table Central China Bio-protein Drug Sales Volume by Application (2018-2023)

    • Table Central China Bio-protein Drug Sales Volume Share by Application (2018-2023)

    • Figure Central China Bio-protein Drug Sales Volume Share by Application (2018-2023)

    • Table South China Bio-protein Drug Production Volume by Type (2018-2023)

    • Table South China Bio-protein Drug Production Volume Share by Type (2018-2023)

    • Figure South China Bio-protein Drug Production Volume Share by Type (2018-2023)

    • Table South China Bio-protein Drug Sales Volume by Application (2018-2023)

    • Table South China Bio-protein Drug Sales Volume Share by Application (2018-2023)

    • Figure South China Bio-protein Drug Sales Volume Share by Application (2018-2023)

    • Table East China Bio-protein Drug Production Volume by Type (2018-2023)

    • Table East China Bio-protein Drug Production Volume Share by Type (2018-2023)

    • Figure East China Bio-protein Drug Production Volume Share by Type (2018-2023)

    • Table East China Bio-protein Drug Sales Volume by Application (2018-2023)

    • Table East China Bio-protein Drug Sales Volume Share by Application (2018-2023)

    • Figure East China Bio-protein Drug Sales Volume Share by Application (2018-2023)

    • Table Northeast China Bio-protein Drug Production Volume by Type (2018-2023)

    • Table Northeast China Bio-protein Drug Production Volume Share by Type (2018-2023)

    • Figure Northeast China Bio-protein Drug Production Volume Share by Type (2018-2023)

    • Table Northeast China Bio-protein Drug Sales Volume by Application (2018-2023)

    • Table Northeast China Bio-protein Drug Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Bio-protein Drug Sales Volume Share by Application (2018-2023)

    • Table Southwest China Bio-protein Drug Production Volume by Type (2018-2023)

    • Table Southwest China Bio-protein Drug Production Volume Share by Type (2018-2023)

    • Figure Southwest China Bio-protein Drug Production Volume Share by Type (2018-2023)

    • Table Southwest China Bio-protein Drug Sales Volume by Application (2018-2023)

    • Table Southwest China Bio-protein Drug Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Bio-protein Drug Sales Volume Share by Application (2018-2023)

    • Table Northwest China Bio-protein Drug Production Volume by Type (2018-2023)

    • Table Northwest China Bio-protein Drug Production Volume Share by Type (2018-2023)

    • Figure Northwest China Bio-protein Drug Production Volume Share by Type (2018-2023)

    • Table Northwest China Bio-protein Drug Sales Volume by Application (2018-2023)

    • Table Northwest China Bio-protein Drug Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Bio-protein Drug Sales Volume Share by Application (2018-2023)

    • Table Amgen Inc Company Profile

    • Table Amgen Inc Bio-protein Drug Revenue, Price and Gross (2018-2023)

    • Table Merck Company Profile

    • Table Merck Bio-protein Drug Revenue, Price and Gross (2018-2023)

    • Table Fresenius kabi Company Profile

    • Table Fresenius kabi Bio-protein Drug Revenue, Price and Gross (2018-2023)

    • Table Dr Reddy’s Laboratories Company Profile

    • Table Dr Reddy’s Laboratories Bio-protein Drug Revenue, Price and Gross (2018-2023)

    • Table ProBioGen AG Company Profile

    • Table ProBioGen AG Bio-protein Drug Revenue, Price and Gross (2018-2023)

    • Table Eli Lilly and Company Company Profile

    • Table Eli Lilly and Company Bio-protein Drug Revenue, Price and Gross (2018-2023)

    • Table Johnson & Johnson Company Profile

    • Table Johnson & Johnson Bio-protein Drug Revenue, Price and Gross (2018-2023)

    • Table Novartis AG Company Profile

    • Table Novartis AG Bio-protein Drug Revenue, Price and Gross (2018-2023)

    • Table Sanofi Company Profile

    • Table Sanofi Bio-protein Drug Revenue, Price and Gross (2018-2023)

    • Table GlaxoSmithKline Company Profile

    • Table GlaxoSmithKline Bio-protein Drug Revenue, Price and Gross (2018-2023)

    • Table Bayer AG Company Profile

    • Table Bayer AG Bio-protein Drug Revenue, Price and Gross (2018-2023)

    • Table Reliance Life Science Pvt Ltd Company Profile

    • Table Reliance Life Science Pvt Ltd Bio-protein Drug Revenue, Price and Gross (2018-2023)

    • Table Biocon Ltd Company Profile

    • Table Biocon Ltd Bio-protein Drug Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.